Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
The World First Liquid Formulation of Recombinant Botulinum Toxin Type A Has Obtained IND Approval by the FDA 2024-09-25 21:18
Flat Medical Strengthens Market Leadership with Acquisition of InjeQ Assets, Including FDA-Designated Breakthrough Device IQ-Tip® 2024-09-25 20:00
Samsung Biologics launches development platforms for enhanced therapeutic efficacy 2024-09-25 19:00
Bestqool Pro Series Iteration: Upgraded Design for Enhanced User Experience 2024-09-24 21:00
XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP 2024-09-24 21:00
LongBio announced the completion of Series B2 financing, led by Qiming Venture Partners 2024-09-24 21:00
Noul Demonstrates 'Expert-Level' AI Diagnostic Performance in Europe… Results from Spain's Carlos III Health Institute 2024-09-24 21:00
Nona Biosciences Enters Strategic Collaboration with Alkyon Therapeutics for Next-Generation Immunotherapeutics Discovery 2024-09-24 20:00
Impressive preliminary objective response rates (ORR) of 36% in NSCLC and 80% in EGFRmut NSCLC: Interim Results of a Phase 1 Study of BC3195, a First-in-Class ADC Targeting CDH3, Presented by BioCity at ESMO 2024 2024-09-23 17:40
WuXi Biologics Included in Hang Seng ESG 50 Index 2024-09-23 17:30
Professor Luo Min Appointed as Chairman of Spine Neurocardiology Interdisciplinary Professional Committee in China to Promote Development of Innovative Heart Disease Treatments 2024-09-23 15:06
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results 2024-09-21 05:30
Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte (TIL) Technology Debuts on ESMO 2024 Annual Meeting 2024-09-20 20:30
Kangpu Completed Bridging Clinical Study of KPG-818 in China 2024-09-20 20:00
CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001 2024-09-20 16:28
Biosyngen Presents Pioneering"Conditional Activation + Armor Enhancement" SUPER-T technology at ESMO 2024 2024-09-19 20:30
NUS scientists discover novel approach to rejuvenate aged egg cells 2024-09-19 18:28
MGI Tech partners with Dasa to enhance health diagnosis with genetic sequencing in Brazil 2024-09-19 11:05
Best Poster of ESMO 2024! Abbisko Announces Updated Clinical Data of Irpagratinib in HCC 2024-09-19 09:00
Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI 2024-09-18 21:30
1 9 10 11 12 13 431